These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 11827710)
1. Pifithrin-alpha, an inhibitor of p53, enhances the genetic instability induced by etoposide (VP16) in human lymphoblastoid cells treated in vitro. Bassi L; Carloni M; Fonti E; Palma de la Peña N; Meschini R; Palitti F Mutat Res; 2002 Feb; 499(2):163-76. PubMed ID: 11827710 [TBL] [Abstract][Full Text] [Related]
2. Relation between DNA repair, apoptosis and chromosomal aberrations in presence of pifithrin-alpha, an inhibitor of p53. Meschini R; Berni A; Ortenzi V; Mancinelli P; Palitti F Mutat Res; 2010 Aug; 701(1):92-7. PubMed ID: 20348016 [TBL] [Abstract][Full Text] [Related]
3. Study on X-ray-induced apoptosis and chromosomal damage in G2 human lymphocytes in the presence of pifithrin-α, an inhibitor of p53. Ortenzi V; Meschini R; Berni A; Mancinelli P; Palitti F Mutat Res; 2011 Nov; 726(1):29-35. PubMed ID: 21889606 [TBL] [Abstract][Full Text] [Related]
4. An evaluation of the ability of pifithrin-alpha and -beta to inhibit p53 function in two wild-type p53 human tumor cell lines. Walton MI; Wilson SC; Hardcastle IR; Mirza AR; Workman P Mol Cancer Ther; 2005 Sep; 4(9):1369-77. PubMed ID: 16170029 [TBL] [Abstract][Full Text] [Related]
5. Fewer chromosome aberrations and earlier apoptosis induced by DNA synthesis inhibitors, a topoisomerase II inhibitor or alkylating agents in human cells with normal compared with mutant p53. Greenwood SK; Armstrong MJ; Hill RB; Bradt CI; Johnson TE; Hilliard CA; Galloway SM Mutat Res; 1998 Jun; 401(1-2):39-53. PubMed ID: 9639670 [TBL] [Abstract][Full Text] [Related]
6. Pifithrin-alpha suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis. Zhang M; Liu W; Ding D; Salvi R Neuroscience; 2003; 120(1):191-205. PubMed ID: 12849752 [TBL] [Abstract][Full Text] [Related]
7. Differential protection and transactivation of P53, P21, Bcl2, PCNA, cyclin G, and MDM2 genes in rat liver and the HepG2 cell line upon exposure to pifithrin. Farah IO; Begum RA; Ishaque AB Biomed Sci Instrum; 2007; 43():116-21. PubMed ID: 17487067 [TBL] [Abstract][Full Text] [Related]
9. Suppression of p53: a new approach to overcome side effects of antitumor therapy. Komarova EA; Gudkov AV Biochemistry (Mosc); 2000 Jan; 65(1):41-8. PubMed ID: 10702639 [TBL] [Abstract][Full Text] [Related]
10. The role of p53-induced apoptosis in cerebral ischemia: effects of the p53 inhibitor pifithrin alpha. Leker RR; Aharonowiz M; Greig NH; Ovadia H Exp Neurol; 2004 Jun; 187(2):478-86. PubMed ID: 15144874 [TBL] [Abstract][Full Text] [Related]
11. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. Culmsee C; Zhu X; Yu QS; Chan SL; Camandola S; Guo Z; Greig NH; Mattson MP J Neurochem; 2001 Apr; 77(1):220-8. PubMed ID: 11279278 [TBL] [Abstract][Full Text] [Related]
12. Radiation induced chromosome aberrations and clonogenic survival in human lymphoblastoid cell lines with different p53 status. Geiger C; Weber KJ; Wenz F Strahlenther Onkol; 1999 Jun; 175(6):289-92. PubMed ID: 10392171 [TBL] [Abstract][Full Text] [Related]
13. Modulation of p53 transcriptional activity by PRIMA-1 and Pifithrin-alpha on staurosporine-induced apoptosis of wild-type and mutated p53 epithelial cells. Charlot JF; Nicolier M; Prétet JL; Mougin C Apoptosis; 2006 May; 11(5):813-27. PubMed ID: 16554962 [TBL] [Abstract][Full Text] [Related]
14. The p53-inhibitor pifithrin-alpha inhibits firefly luciferase activity in vivo and in vitro. Rocha S; Campbell KJ; Roche KC; Perkins ND BMC Mol Biol; 2003 Sep; 4():9. PubMed ID: 12967348 [TBL] [Abstract][Full Text] [Related]
16. Pifithrin-α as a potential cytoprotective agent in radiotherapy: protection of normal tissue without decreasing therapeutic efficacy in glioma cells. Sinn B; Schulze J; Schroeder G; Konschak R; Freyer D; Budach V; Tinhofer I Radiat Res; 2010 Nov; 174(5):601-10. PubMed ID: 20718603 [TBL] [Abstract][Full Text] [Related]
17. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Komarov PG; Komarova EA; Kondratov RV; Christov-Tselkov K; Coon JS; Chernov MV; Gudkov AV Science; 1999 Sep; 285(5434):1733-7. PubMed ID: 10481009 [TBL] [Abstract][Full Text] [Related]
18. Imino-tetrahydro-benzothiazole derivatives as p53 inhibitors: discovery of a highly potent in vivo inhibitor and its action mechanism. Pietrancosta N; Moumen A; Dono R; Lingor P; Planchamp V; Lamballe F; Bähr M; Kraus JL; Maina F J Med Chem; 2006 Jun; 49(12):3645-52. PubMed ID: 16759106 [TBL] [Abstract][Full Text] [Related]
19. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Mahyar-Roemer M; Roemer K Oncogene; 2001 Jun; 20(26):3387-98. PubMed ID: 11423989 [TBL] [Abstract][Full Text] [Related]
20. The novel p53-dependent metastatic and apoptotic pathway induced by vitexin in human oral cancer OC2 cells. Yang SH; Liao PH; Pan YF; Chen SL; Chou SS; Chou MY Phytother Res; 2013 Aug; 27(8):1154-61. PubMed ID: 22976055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]